Asia Pacific Cardiac Biomarkers Testing Market 2019-2025)
The Asia Pacific Cardiac Biomarkers Testing Market would witness market growth of 12.8% CAGR during the forecast period (2019–2025).
Asia Pacific would emerge as one of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of a large number of undiagnosed cardiac patients, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. Quick cardiac checkup (QCC).
Preventing heart disease by tracking heart conditions through cardiac biomarker screening is the profound strategy for achieving rapid results for instant diagnosis and therapy. Cardiac biomarkers are traceable protein-based materials used as an indicator of the biological state and used for heart-related educational and prognostic reasons. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infarction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers used widely as an integrated diagnostic approach for cardiovascular diseases include CK-MB, myoglobin, troponin I and T, BNPs, IMA, and many others.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
Asia Pacific would emerge as one of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of a large number of undiagnosed cardiac patients, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. Quick cardiac checkup (QCC).
Preventing heart disease by tracking heart conditions through cardiac biomarker screening is the profound strategy for achieving rapid results for instant diagnosis and therapy. Cardiac biomarkers are traceable protein-based materials used as an indicator of the biological state and used for heart-related educational and prognostic reasons. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infarction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers used widely as an integrated diagnostic approach for cardiovascular diseases include CK-MB, myoglobin, troponin I and T, BNPs, IMA, and many others.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
- Creatine Kinase (CK-MB)
- Troponins
- Myoglobin
- Natriuretic Peptides (BNP and NT-proBNP)
- Ischemia Modified Albumin
- Others
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- Point of Care Testing
- Laboratory Testing
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Trivitron Healthcare Pvt. Ltd.
- Abbott Laboratories
- Siemens AG
- Becton, Dickinson AND Company
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Limited
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson and Johnson
- Quidel Corporation
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cardiac Biomarkers Testing Market, by Type
1.4.2 Asia Pacific Cardiac Biomarkers Testing Market, by Application
1.4.3 Asia Pacific Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Asia Pacific Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
3.1.2 Asia Pacific Troponins Market by Country
3.1.3 Asia Pacific Myoglobin Market by Country
3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
3.1.6 Asia Pacific Others Market by Country
CHAPTER 4. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 Asia Pacific Myocardial Infarction Market by Country
4.1.2 Asia Pacific Congestive Heart Failure Market by Country
4.1.3 Asia Pacific Acute Coronary Syndrome Market by Country
4.1.4 Asia Pacific Atherosclerosis Market by Country
4.1.5 Asia Pacific Others Market by Country
CHAPTER 5. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 Asia Pacific Point of Care Testing Market by Country
5.1.2 Asia Pacific Laboratory Testing Market by Country
CHAPTER 6. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 China Cardiac Biomarkers Testing Market
6.1.1 China Cardiac Biomarkers Testing Market by Type
6.1.2 China Cardiac Biomarkers Testing Market by Application
6.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
6.2 Japan Cardiac Biomarkers Testing Market
6.2.1 Japan Cardiac Biomarkers Testing Market by Type
6.2.2 Japan Cardiac Biomarkers Testing Market by Application
6.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
6.3 India Cardiac Biomarkers Testing Market
6.3.1 India Cardiac Biomarkers Testing Market by Type
6.3.2 India Cardiac Biomarkers Testing Market by Application
6.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
6.4 South Korea Cardiac Biomarkers Testing Market
6.4.1 South Korea Cardiac Biomarkers Testing Market by Type
6.4.2 South Korea Cardiac Biomarkers Testing Market by Application
6.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
6.5 Singapore Cardiac Biomarkers Testing Market
6.5.1 Singapore Cardiac Biomarkers Testing Market by Type
6.5.2 Singapore Cardiac Biomarkers Testing Market by Application
6.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
6.6 Malaysia Cardiac Biomarkers Testing Market
6.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
6.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
6.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
6.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
6.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
6.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
6.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cardiac Biomarkers Testing Market, by Type
1.4.2 Asia Pacific Cardiac Biomarkers Testing Market, by Application
1.4.3 Asia Pacific Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Asia Pacific Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
3.1.2 Asia Pacific Troponins Market by Country
3.1.3 Asia Pacific Myoglobin Market by Country
3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
3.1.6 Asia Pacific Others Market by Country
CHAPTER 4. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 Asia Pacific Myocardial Infarction Market by Country
4.1.2 Asia Pacific Congestive Heart Failure Market by Country
4.1.3 Asia Pacific Acute Coronary Syndrome Market by Country
4.1.4 Asia Pacific Atherosclerosis Market by Country
4.1.5 Asia Pacific Others Market by Country
CHAPTER 5. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 Asia Pacific Point of Care Testing Market by Country
5.1.2 Asia Pacific Laboratory Testing Market by Country
CHAPTER 6. ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 China Cardiac Biomarkers Testing Market
6.1.1 China Cardiac Biomarkers Testing Market by Type
6.1.2 China Cardiac Biomarkers Testing Market by Application
6.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
6.2 Japan Cardiac Biomarkers Testing Market
6.2.1 Japan Cardiac Biomarkers Testing Market by Type
6.2.2 Japan Cardiac Biomarkers Testing Market by Application
6.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
6.3 India Cardiac Biomarkers Testing Market
6.3.1 India Cardiac Biomarkers Testing Market by Type
6.3.2 India Cardiac Biomarkers Testing Market by Application
6.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
6.4 South Korea Cardiac Biomarkers Testing Market
6.4.1 South Korea Cardiac Biomarkers Testing Market by Type
6.4.2 South Korea Cardiac Biomarkers Testing Market by Application
6.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
6.5 Singapore Cardiac Biomarkers Testing Market
6.5.1 Singapore Cardiac Biomarkers Testing Market by Type
6.5.2 Singapore Cardiac Biomarkers Testing Market by Application
6.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
6.6 Malaysia Cardiac Biomarkers Testing Market
6.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
6.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
6.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
6.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
6.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
6.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
6.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
LIST OF TABLES
TABLE 1 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 77 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 82 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 94 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 95 KEY INFORMATION – SIEMENS AG
TABLE 96 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 97 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 98 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 99 KEY INFORMATION – DANAHER CORPORATION
TABLE 100 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 101 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 102 KEY INFORMATION – QUIDEL CORPORATION
TABLE 1 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 77 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 82 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 94 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 95 KEY INFORMATION – SIEMENS AG
TABLE 96 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 97 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 98 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 99 KEY INFORMATION – DANAHER CORPORATION
TABLE 100 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 101 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 102 KEY INFORMATION – QUIDEL CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
